Investigators of this study sought to compare the efficacy of a community health nursing intervention vs standard of care to improve self-management of pelvic inflammatory disease.
Investigators used electronic medical record data and OSOM® Trichomonas Rapid Tests to assess the prevalence of Trichomonas vaginalis among women attending New York City sexual health clinics in 2016.
Investigators found a decline in pediatric herpes zoster incidence and a significantly lower incidence among vaccinated children.
The FDA has granted 510(k) clearance to binx io for a molecular point-of-care diagnostic testing platform for detecting chlamydia and gonorrhea in approximately 30 minutes.
A 2-dose course of recombinant zoster vaccine decreased the incidence of herpes zoster in adults who had undergone recent autologous hematopoietic stem cell transplantation.
Researchers at the National Institute for Health Research Imperial Clinical Research Facility at Hammersmith Hospital in London have demonstrated immunogenic responses in the first human phase 1 trial of a novel vaccine for the prevention of C trachomatis infection.
Emerging evidence suggests that Ureaplasma spp, specifically Ureaplasma urealyticum but not Ureaplasma parvum, may play a causal role in the development of nongonococcal urethritis and infertility in men.
Despite these soaring rates, sexual behavior and STD risk are not common topics of discussion between patients and clinicians.
The majority of patients who chose to receive notification of STD results via electronic messaging, including via text message, and/or email, to be satisfactory and easy.
A recent study evaluated the frequency and characteristics that predicted coinfection of M genitalium and chlamydia in women.
Among noninstitutionalized adolescents and adults in the United States between 2013 and 2016, 1.3% tested positive for Trichomonas vaginalis infection.
The CDC ACIP has voted to expand routine and catch-up HPV vaccination in males through 26 years of age who are inadequately vaccinated.
Less than 60% of prescriptions for the treatment of STIs in adolescents seeking care in emergency departments were filled.
The FDA has granted Breakthrough Device designation to ResistancePlus GC,, a test that detects ciprofloxacin susceptibility.
Persistent human papillomavirus infections may have minimal changes in viral load
From 2003 to 2014, there was a decrease in herpes zoster incidence among children, with lower incidence rates for varicella-vaccinated versus unvaccinated children.
The estimated incidence of urogenital infections with chlamydia, gonorrhea, trichomoniasis, and syphilis was 376.4 million in 15- to 49-year-old men and women in 2016.
Less than 60 percent of prescriptions for the treatment of STIs among teens seeking care in the emergency department are filled.
Point-of-care testing may improve infection management in women with urogenital infection, according to a study published in Lancet Infectious Diseases. With an estimated 357 million new curable infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Treponema pallidum occuring in 2012, sexually transmitted infections and other urogenital infections are a major disease burden worldwide.…
Ceftriaxone remains the superior first-line treatment for gonorrhea compared with gentamicin.